146 related articles for article (PubMed ID: 21512110)
1. Immunochemical faecal occult blood tests have superior stability and analytical performance characteristics over guaiac-based tests in a controlled in vitro study.
Lee CS; O'Gorman P; Walsh P; Qasim A; McNamara D; O'Morain CA; Boran GP
J Clin Pathol; 2011 Jun; 64(6):524-8. PubMed ID: 21512110
[TBL] [Abstract][Full Text] [Related]
2. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
3. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
Brenner H; Tao S
Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
[TBL] [Abstract][Full Text] [Related]
4. Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening.
Guittet L; Guillaume E; Levillain R; Beley P; Tichet J; Lantieri O; Launoy G
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1492-501. PubMed ID: 21576271
[TBL] [Abstract][Full Text] [Related]
5. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
6. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.
Duffy MJ; van Rossum LG; van Turenhout ST; Malminiemi O; Sturgeon C; Lamerz R; Nicolini A; Haglund C; Holubec L; Fraser CG; Halloran SP
Int J Cancer; 2011 Jan; 128(1):3-11. PubMed ID: 20824704
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
[TBL] [Abstract][Full Text] [Related]
8. Colon cancer screening: which non-invasive filter tests?
Pox C
Dig Dis; 2011; 29 Suppl 1():56-9. PubMed ID: 22104755
[TBL] [Abstract][Full Text] [Related]
9. Effect of season and ambient temperature on outcome of guaiac-based faecal occult blood tests performed for colorectal cancer screening.
Hunter JP; Saratzis A; Froggatt P; Harmston C
Colorectal Dis; 2012 Sep; 14(9):1084-9. PubMed ID: 22122559
[TBL] [Abstract][Full Text] [Related]
10. A new immunological test strip device for the rapid, qualitative detection of faecal occult blood.
Trojan J; Povse N; Schröder O; Stein J
Z Gastroenterol; 2002 Nov; 40(11):921-4. PubMed ID: 12436369
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test.
Birkenfeld S; Belfer RG; Chared M; Vilkin A; Barchana M; Lifshitz I; Fruchter D; Aronski D; Balicer R; Niv Y; Levi Z
J Med Screen; 2011; 18(3):135-41. PubMed ID: 22045822
[TBL] [Abstract][Full Text] [Related]
13. Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test.
Oort FA; Terhaar Sive Droste JS; Van Der Hulst RW; Van Heukelem HA; Loffeld RJ; Wesdorp IC; Van Wanrooij RL; De Baaij L; Mutsaers ER; van der Reijt S; Coupe VM; Berkhof J; Bouman AA; Meijer GA; Mulder CJ
Aliment Pharmacol Ther; 2010 Feb; 31(3):432-9. PubMed ID: 19878150
[TBL] [Abstract][Full Text] [Related]
14. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
Lohsiriwat V; Thavichaigarn P; Awapittaya B
J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis.
Zhu MM; Xu XT; Nie F; Tong JL; Xiao SD; Ran ZH
J Dig Dis; 2010 Jun; 11(3):148-60. PubMed ID: 20579218
[TBL] [Abstract][Full Text] [Related]
16. Performance improvements of stool-based screening tests.
van Dam L; Kuipers EJ; van Leerdam ME
Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):479-92. PubMed ID: 20833351
[TBL] [Abstract][Full Text] [Related]
17. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
18. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
[TBL] [Abstract][Full Text] [Related]
19. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
[TBL] [Abstract][Full Text] [Related]
20. Impact of changing from a guaiac faecal occult blood test to a faecal immunochemical test in a national screening programme: Results from a pilot study within the national bowel cancer screening programme in England.
Benton SC; Piggott C; Blyuss O; Li SJ; Mathews C; Carroll M; Duffy S
J Med Screen; 2021 Dec; 28(4):426-432. PubMed ID: 33983066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
